Accunea
Generated by Meeveem AI
"Pioneering real-time kidney monitoring to ensure every transplant counts"
Kidderminster
•1 - 10 Employees
•Medical Devices
About Accunea
Accunea develops RenoSure, a medical device that provides continuous, real-time monitoring of kidney function for transplant patients. The technology uses advanced biosensing to track multiple biomarkers of kidney health, giving clinicians dynamic molecular insights before and after transplantation. This helps reduce viable organs discarded and supports safer patient recovery. Transplant centres face difficult decisions about organ viability with limited data. Accunea addresses this by delivering point-of-care diagnostics that empower surgeons and nephrologists to make informed choices. The system integrates into hospital workflows, providing actionable intelligence for patients waiting for life-saving treatment.
6
Team Members
2017
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where no viable kidney is wasted, where every patient on dialysis has access to a functioning transplant, and where organ allocation is guided by objective, real-time biological data rather than uncertainty.
Our Mission
Accunea's mission is to improve kidney transplant outcomes by providing clinicians with continuous, real-time organ function monitoring that reduces organ waste and supports safer patient recovery.